MapHospitals
Hospital do Câncer IV

Hospital do Câncer IV

Rio de Janeiro
VS
IBOL - Brazilian Institute of Ophthalmology Ltda

IBOL - Brazilian Institute of...

Rio de Janeiro
Feature Hospital do Câncer IV IBOL - Brazilian Institute o...
Verified No No
Rating
(0 reviews)
(0 reviews)
City Rio de Janeiro Rio de Janeiro
Address R. Visc. de Santa Isabel, 274 - A - Vila Isabel, Rio de Janeiro - RJ, 20560-121, Brazil Praia de Botafogo, 206 - Botafogo, Rio de Janeiro - RJ, 22250-145, Brazil
Enquiries 0 0
Phone +55 21 3207-3700 +55 21 3237-9200
Specialities Count 3 3
Website Visit Visit
Specialities
Oncology Nephrology Otorhinolaryngology
Neurology Ophthalmologists Otorhinolaryngology

Shared (1)

Otorhinolaryngology

Only at Hospital do Câncer IV

Oncology Nephrology

Only at IBOL - Brazilian Institut...

Neurology Ophthalmologists

Hospital do Câncer IV vs IBOL - Brazilian Institute of Ophthalmology Ltda: Detailed Comparison

Choosing the right hospital is a critical decision for patients seeking quality healthcare. Hospital do Câncer IV, located in Rio de Janeiro, offers 3 medical specialities . Meanwhile, IBOL - Brazilian Institute of Ophthalmology Ltda in Rio de Janeiro provides 3 specialities .

Both hospitals share 1 common speciality, including Otorhinolaryngology. This means patients looking for Otorhinolaryngology can consider either hospital based on location, reviews, and other preferences.

Hospital do Câncer IV uniquely offers Oncology, Nephrology. IBOL - Brazilian Institute of Ophthalmology Ltda stands out with Neurology, Ophthalmologists.

For detailed information, visit the individual hospital pages: Hospital do Câncer IV or IBOL - Brazilian Institute of Ophthalmology Ltda. You can also use our hospital comparison tool to compare up to 3 hospitals side by side.

Get Free Consultation

We'll connect you with the right hospital

Your Details Treatment Info

Secure Reply in 24h No spam
hospital(s) selected
Compare Now
We use cookies and analytics to improve your experience. By continuing to browse, you consent to our use of cookies. Privacy Policy